Instead, contact both your prescribing provider and our eye office promptly so we can assess whether the vision changes require immediate attention or simply closer monitoring while continuing therapy
Its important to understand how these treatments work, and what the evidence shows regarding their role in weight loss
How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors
Shoshani O, Livne E, Armoni M, Shupak A, Berger J, Ramon Y, Fodor L, Gilhar A, Peled IJ, Ullmann Y
Effect of oral semaglutide compared with placebo and subcutaneous semaglutide on glycemic control in patients with type 2 diabetes: a randomized clinical trial